- Home
- TBPH vs ADSE Comparison
TBPH vs ADSE Comparison
Compare TBPH & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBPH | ADSE |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | Ireland |
| Employees | N/A | 302 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 697.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | TBPH | ADSE |
|---|---|---|
| Price | $16.77 | $12.14 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.40 | N/A |
| AVG Volume (30 Days) | ★ 402.7K | 7.2K |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | ★ 2.06 | N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $549.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.15 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.33 | $7.89 |
| 52 Week High | $21.03 | $13.90 |
Technical Indicators
Market Signals| Indicator | TBPH | ADSE |
|---|---|---|
| Relative Strength Index (RSI) | 56.91 | 58.21 |
| Support Level | $13.41 | $11.07 |
| Resistance Level | $17.24 | $12.89 |
| Average True Range (ATR) | 0.41 | 0.49 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 57.01 | 100.00 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. ADSE generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.